StockData
CytoDyn Inc. logo

CytoDyn Inc. (CYDY) stock

CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 14, 2026Score 4/30
$0.25+0.02 (+9.53%)

Close on Oct 19, 2026Market cap $345.56MP/E –Yield –

CytoDyn shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

CytoDyn's shares outstanding was 1.38B at Aug 31, 2026. For fiscal 2026 it was 1.29B, up 3.7% from the year before. Over ten years it grew 29.7% a year on average. The highest annual figure on record is 1.29B in fiscal 2026.

Annual shares outstanding

PeriodPeriod endValueChange
FY2026May 31, 20261.29B+3.7%
FY2025May 31, 20251.24B+28.2%
FY2024May 31, 2024970M+15.9%
FY2023May 31, 2023837M+23.6%
FY2022May 31, 2022677M+15.2%
FY2021May 31, 2021588M+39.5%
FY2020May 31, 2020421M+54.8%
FY2019May 31, 2019272M+55.6%
FY2018May 31, 2018175M+26.7%
FY2017May 31, 2017138M+44.6%
FY2016May 31, 201695M+63.5%
FY2015May 31, 201558M+24.5%
FY2014May 31, 201447M+56.6%
FY2013May 31, 201330M+21.6%
FY2012May 31, 201225M+16.8%
FY2011May 31, 201121M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Aug 31, 20261.38B+10.4%
Q4 FY2026CQ2 2026May 31, 20261.37B+5.7%
Q3 FY2026CQ1 2026Feb 28, 20261.28B+3.8%
Q2 FY2026CQ4 2025Nov 30, 20251.26B+3.2%
Q1 FY2026CQ3 2025Aug 31, 20251.25B+4.5%
Q4 FY2025CQ2 2025May 31, 20251.30B+27.8%
Q3 FY2025CQ1 2025Feb 28, 20251.23B+25.1%
Q2 FY2025CQ4 2024Nov 30, 20241.22B+27.4%
Q1 FY2025CQ3 2024Aug 31, 20241.20B+29.7%
Q4 FY2024CQ2 2024May 31, 20241.01B+24.6%
Q3 FY2024CQ1 2024Feb 29, 2024982M+24.7%
Q2 FY2024CQ4 2023Nov 30, 2023959M+33.7%
Q1 FY2024CQ3 2023Aug 31, 2023924M+32.8%
Q2 FY2023CQ4 2022Nov 30, 2022813M+22.8%
Q1 FY2023CQ3 2022Aug 31, 2022788M+24.5%
Q4 FY2022CQ2 2022May 31, 2022717M+27.1%
Q3 FY2022CQ1 2022Feb 28, 2022696M+120278.9%
Q2 FY2022CQ4 2021Nov 30, 2021663M+14.6%
Q1 FY2022CQ3 2021Aug 31, 2021633M+13.9%
Q4 FY2021CQ2 2021May 31, 2021565M+14.2%
Q3 FY2021CQ1 2021Feb 28, 20211M-99.9%
Q2 FY2021CQ4 2020Nov 30, 2020578M+48.5%
Q1 FY2021CQ3 2020Aug 31, 2020556M+52.4%
Q4 FY2020CQ2 2020May 31, 2020494M+56.6%
Q3 FY2020CQ1 2020Feb 29, 2020432M+46.2%
Q2 FY2020CQ4 2019Nov 30, 2019389M+50.2%
Q1 FY2020CQ3 2019Aug 31, 2019365M+66.8%
Q4 FY2019CQ2 2019May 31, 2019316M+48.8%
Q3 FY2019CQ1 2019Feb 28, 2019296M+66.0%
Q2 FY2019CQ4 2018Nov 30, 2018259M+64.1%
Q1 FY2019CQ3 2018Aug 31, 2018219M+44.1%
Q4 FY2018CQ2 2018May 31, 2018212M+41.8%
Q3 FY2018CQ1 2018Feb 28, 2018178M+25.3%
Q2 FY2018CQ4 2017Nov 30, 2017158M+16.0%
Q1 FY2018CQ3 2017Aug 31, 2017152M+22.0%
Q4 FY2017CQ2 2017May 31, 2017150M–
Q3 FY2017CQ1 2017Feb 28, 2017142M–
Q2 FY2017CQ4 2016Nov 30, 2016136M–
Q1 FY2017CQ3 2016Aug 31, 2016124M–

More CytoDyn figures

See a number that looks wrong?